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Making Into Routine Practice?
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Demetria McNeal, Daniel D. Matlock, and Russell E. Glasgow
Abstract
Shared decision making (SDM) is not widely practiced in routine care due to a variety of organizational, provider,
patient, and contextual factors. This article explores how implementation science—which encourages attention to the
multilevel contextual factors that influence the adoption, implementation, and sustainment of health care practices—
can provide useful insights for increasing SDM use in routine practice. We engaged with stakeholders representing
different organizations and geographic locations over three phases: 1) multidisciplinary workgroup meeting compris-
ing researchers and clinicians (n = 11); 2) survey among a purposive sample of 47 patient advocates, clinicians,
health care system leaders, funders, policymakers, and researchers; and 3) working session among diverse stake-
holders (n = 30). The workgroup meeting identified priorities for action and research, which included targeting mul-
tiple audiences and levels, shifting culture toward valuing and supporting SDM, and considering contextual factors
influencing SDM implementation. Survey respondents provided recommendations for increasing adoption, imple-
mentation, and maintenance of SDM in practice including providing tools to support SDM, obtaining stakeholders’
involvement, and raising awareness of the importance of SDM. Stakeholders in the working session provided recom-
mendations on the design of a guide for implementation of SDM in clinical settings, strategies to disseminate educa-
tional curricula on SDM, and strategies to influence policies to increase SDM use. These specific recommendations
serve as a call to action to pursuing specific promising strategies aimed at increasing SDM use in practice and
enhance understanding of the perspectives of diverse stakeholders at multiple levels from an implementation science
perspective that appear fruitful for further study and application.
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Shared decision making (SDM) is defined as a collabora-
tive process that encourages patients and their providers
to make health care decisions together, taking into
account the best clinical evidence available to weigh the
risks and benefits, as well as the patient’s values and pre-
ferences.1 SDM has been referred to as a pinnacle of
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patient-centered care.2 From the bioethical perspective,
it is also viewed as the right thing to do.3 SDM is con-
ceptualized as a complex set of behaviors that require
engagement beyond the patient–provider dyad level,
involving the health care team, health system, and health
policy levels.4
Impetus for SDM Implementation
Recent trends in health care and health-related research
have significant implications for implementing SDM in
practice. First, there is growing emphasis on ensuring
patient engagement and patient-centered care, develop-
ment of SDM tools, training,4 policies, and incentives to
promote SDM (e.g., Affordable Care Act provisions to
encourage SDM).5,6 Second, there is increased recogni-
tion of the need for and investment in pragmatic research
and comparative effectiveness research in patient-
centered care as evidenced by the establishment of the
Patient Centered Outcomes Research Institute in 2010.7
Third, the growing field of dissemination and implemen-
tation science8,9 has fueled a focus on population impact
and the importance of translation of health care inter-
ventions by emphasizing factors that maximize reach,
implementation, feasibility, and sustainability while
minimizing cost and addressing disparities.
Evidence of Effects of SDM and Implementation
Barriers and Facilitators of SDM
A growing body of evidence suggests SDM is associated
with reduced decisional conflict and improved patient
knowledge, participation, accurate risk perceptions,
behaviors, treatment satisfaction, completion, and
patient-reported outcomes in the short term.4,10–13
However, there is limited research on the potential
consequences of SDM on patients at distal and distant
time points or effects of SDM on clinicians, relation-
ships with patients and within the care teams, the
health care organization, and the health care system.14
Despite the availability of SDM interventions—defined
as efforts, approaches, or tools applied at multiple lev-
els to support the use of SDM in practice including
decision support tools, training, policies, and incentives
to promote collaborative deliberation between patients
and their health care providers—SDM is not widely
practiced in routine care.15 Research has documented
extensively the key barriers and facilitators of using
SDM at multiple levels. Examples of barriers include
health care professionals’ indifference16; lack of consid-
eration of outcomes of SDM at the team, organization,
or health care system culture17; time constraints,
patients’ interest and preparedness in perceived SDM;
lack of applicability for clinical situations (e.g., when
there is a medically preferable treatment decision); and
funding models and incentives that conflict with SDM
goals (e.g., fee-for-service or pay for performance).18
Facilitators include health professionals’ motivation,
perceptions of positive outcomes of SDM on patient
outcomes, clinical process, supportive leadership at all
levels to integrate SDM into practice, constant evalua-
tion and iterative improvement, and embedding SDM
in physician training and culture.19–21 In this article, we
seek to expand on prior literature that describes the
multilevel factors of integrating SDM into practice by
examining these issues through an implementation sci-
ence perspective8,9 and obtaining concrete actionable
recommendations from diverse stakeholders at each
level (patient, provider and care team, organization,
and policymakers) on how to promote the adoption,
implementation, and maintenance of SDM in practice.
Leveraging Implementation Science to Translate
SDM Into Routine Practice
Implementation science provides a framework to inform
the integration of SDM into routine practice because it
acknowledges that successful implementation of health
care interventions into practice depends on addressing
contextual and multilevel factors.8 Also, it addresses the
balance between fidelity of an intervention (to evidence-
based principles and key components of an intervention)
and adaptation of the intervention to best suit each
local setting, available resources, and patients.22
Implementation science can also help broaden concep-
tualization and measurement of outcomes to address
population reach and impact, generalizability of results,
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and feasibility of applying different SDM interventions.
Maybe most important, implementation science perspec-
tives are increasingly being used to ‘‘design for dissemi-
nation and sustainability.’’23
Our work was informed by an implementation science
framework, the Practical Robust Implementation and
Sustainability Model (PRISM),24 which helps researchers
consider related concepts from diffusion of innovations,
social ecology, the PRECEDE/PROCEED model, qual-
ity improvement, the Chronic Care Model, and the RE-
AIM framework.25–31 PRISM considers how an interven-
tion’s design, the external environment, implementation
and sustainability infrastructure, and the characteristics
of recipients of the intervention (i.e., the adopting organi-
zation, providers, and patients) interact to influence the
intervention’s adoption, implementation, and mainte-
nance. PRISM has been utilized in assessing the perspec-
tives of stakeholders toward the implementation of a
variety of health care services (e.g., population-based col-
orectal cancer screening and well-child care within large
health care delivery systems).32,33 In this current work,
we focused on the adoption, implementation, and main-
tenance dimensions of the PRISM.
This work was further guided by findings from SDM
implementation projects that described the contextual
factors, processes, barriers, and facilitators at multiple
levels to successful integration of SDM interventions
within health care practices. For instance, Lin and col-
leagues evaluated the dissemination of decision aids for
facilitating patient engagement and SDM for two
topics—colorectal cancer screening and low back
pain—within five primary care practices in Northern
California.34 The authors reported low distribution of
decision aids; approximately 10% of eligible patients
received these decision aids during the project period.
They identified significant structural and cultural bar-
riers to implementing the integration of decision aids dis-
tribution. These included lack of physician training,
physicians’ reluctance to utilize SDM, time constraints,
and the lack of a supportive clinic culture.34 In addition,
King and Moulton described the lessons from the Group
Health Shared Decision-Making Demonstration Project
to distribute decision aids for 12 preference-sensitive sur-
gical conditions (e.g., knee and hip osteoarthritis, benign
prostatic hyperplasia, and early-stage breast cancer).20
The authors acknowledged the importance of the
Washington state legislature’s role in catalyzing mean-
ingful changes within health care systems to encourage
SDM into clinical practice.20 They further identified
important factors from Group Health’s experience that
might inform other institutions interested in integration
of SDM into routine clinical care. These factors include
having substantial leadership committed to integrating
SDM into practice at all levels of the organization, con-
ducting constant evaluation and iterative refinement to
the delivery of decision aids, and supporting physicians
with training and efforts to change culture at the system-
wide level.20 A recent scoping review by Scholl and col-
leagues identified several organizational characteristics
that influence SDM implementation including leader-
ship, culture, teamwork, resources, priorities, and work-
flows reported in implementation projects.17 The authors
also described health care system–level characteristics
including incentives, policies and guidelines, culture, and
provider education and licensing that were described in
the literature.17
Figure 1 illustrates a proposed conceptual model inte-
grating the key contextual factors and cross-cutting
implementation issues that influence SDM adoption,
implementation, and maintenance based on the PRISM
framework and prior literature on SDM implementation.
For instance, as described in PRISM, in considering
implementation of an evidence-based SDM intervention
into practice, it is critical to first understand the charac-
teristics, values, resources, contingencies, and priorities
of each of the target audiences at multiple contextual
levels including health care organization leaders (and
guidelines), clinicians and health care team, policy and
financial issues, and patients and their families. It is also
important to consider cross-cutting issues across these
audiences including the characteristics of the health care
decision and implementation factors associated with the
intervention. In sum, these contextual factors influence
the extent of successful adoption, implementation, and
maintenance of the SDM intervention.
Population Health Impact of Designing SDM
Interventions for Dissemination and Sustainment
The convergence of the growing emphasis on patient-
centered care in health care, availability of evidence-
based SDM interventions, and advances in implementa-
tion science present new opportunities for facilitating
integration of SDM into routine care. At the same time,
they provide an impetus to look closely at the current
state of evidence and application of that knowledge, and
to identify the key gaps in SDM reach, adoption, imple-
mentation, and sustainment within diverse practices.
Evidence-based SDM, if consistently implemented with
fidelity, has the potential to realize the benefits for indi-
vidual patients and families, improve the quality of
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medical decision making, ensure respect for patient pre-
ferences, minimize adverse effects from under- or overu-
tilization of care, and ultimately improve patient and
population outcomes and reduce health inequalities.35
Implementation science has the potential to help realize
the benefits of progress in each of these areas, to sustain
effective SDM interventions (or discontinue unsuccessful
ones) and to scale up to different settings and popula-
tions36 to improve population health outcomes, and
reduce disparities in care. For instance, researchers pro-
posed implementing SDM to reduce health care dispari-
ties through designing materials that will help people
with lower literacy or socioeconomic status with medical
decision making.37 A systematic review found that inter-
ventions to support SDM improved knowledge,
informed choice, and participation in decision making
among patients from disadvantaged populations more
than patients with higher literacy, education, and socioe-
conomic status and suggested that supporting SDM
would help reduce health inequalities.35
Objectives
The objectives of this work are threefold. First, we sum-
marize input from experts in SDM and implementation
science on priorities for actionable approaches for
improving SDM use and a research agenda that would
better integrate SDM and implementation science.
Second, beyond describing facilitators and challenges to
using SDM, we aimed to generate concrete and actionable
recommendations from stakeholders at multiple levels to
increase the adoption, implementation, and maintenance/
sustainment of SDM into practice. Third, we aimed to
obtain suggestions for strategies from various stake-
holders on how to address specific action priorities.
Methods
Overview
We addressed the study objectives through engaging with
diverse stakeholders across different organizations and
Figure 1 Contextual factors influencing shared decision making adoption, implementation, and maintenance.
4 MDM Policy & Practice 00(0)
geographic locations in implementing SDM interventions
over three phases. In Phase 1, we convened a multidisci-
plinary workgroup meeting of researchers and clinicians
to discuss illustrative cases of using SDM in cancer pre-
vention and control, with the goal of applying an imple-
mentation science lens to the challenges and facilitators
to SDM use. In Phase 2, we conducted a survey among a
purposive sample of patient advocates, clinicians, health
care system leaders, funders, policymakers, and research-
ers to obtain actionable recommendations to improve
SDM adoption, implementation, and sustainment in a
variety of cancer care scenarios. By actionable recom-
mendations, we mean to encompass discrete implementa-
tion strategies for getting evidence-based practices into
routine use as described in existing literature,38–41 as well
as recommendations that address the ‘‘how’’ to do so,
such as recommendations that are feasible, achievable,
align with levels of resources, training, and time available
in most settings from stakeholders’ perspectives. In Phase
3, we invited diverse stakeholders representing different
roles and organizations to a working session to generate
recommendations to apply implementation science to
increase SDM use in practice through training, tools to
support SDM use, and policy change. We synthesized the
recommendations from all three phases as a call to action
and research to increase the use of SDM in routine care.
Phase 1: Expert Panel Workgroup
Participants. We convened an expert panel composed of
researchers and health care practitioners across different
disciplines (including implementation science, health
communication, decision science, health services, oncol-
ogy, gerontology, chronic care, and patient-centered
outcomes research; n = 11) for a workgroup meeting
at the 2016 Annual Conference on the Science of
Dissemination and Implementation in Health. The
objective of the meeting was to generate input on priori-
ties for actionable approaches for improving SDM use
and a research agenda that would better integrate SDM
and implementation science. During the meeting, partici-
pants considered three clinical decision scenarios where
patients faced a decision—human papillomavirus (HPV)
vaccination for cancer prevention, lung cancer screening
with low-dose computed tomography (CT) scans for
early detection, and advance care planning with patients
diagnosed with advanced cancers. We selected these sce-
narios to highlight certain variations in the contextual
factors related to different decisions. For instance, in the
case of HPV vaccination, the decision is typically made
in a nonurgent, outpatient setting. The vaccination is
generally considered by most clinicians to be low in com-
plexity, has minimal adverse effects, is nonreversible, and
not preference-sensitive. In comparison, the scenario for
CT scans for lung cancer screening is low-to-moderate
complexity; findings may trigger additional invasive
diagnostic tests such as biopsies and treatments, which
could pose adverse effects. The patient may also require
recurrent scans for up to 3 years. Advance care planning
creates a third scenario where patients are tasked with
forecasting about decisions related to the end of their
lives. The workgroup members discussed what the prior-
ity areas are to focus, key challenges, and opportunities
to integrate SDM and implementation science.
Following the meeting, a core group from this work-
group (RG, DDM, KM, and AT) synthesized the input
from the meeting on the key contextual factors and
implementation issues in the use of SDM.
Summary of Findings. The workgroup identified three
key priorities for action and research to increase SDM
use from an implementation science perspective. First,
members recommended targeting multiple audiences and
levels in promoting wide SDM use. For instance, beyond
targeting interventions at the main enactors of SDM
(i.e., patients and clinicians), efforts should engage health
care organizational leaders, policymakers, and funders
and intervene at the individual, interpersonal, organiza-
tional, and policy levels. Second, generating the evidence
base for SDM interventions is necessary but insufficient.
Beyond generating evidence-based SDM interventions,
greater attention is needed on shifting the culture toward
valuing SDM and providing the necessary organizational
infrastructure, incentives, and policies to support SDM.
Third, there was consensus within the workgroup that
one size does not fit all and that it is critical to consider
contextual factors that would influence implementing
SDM interventions in different settings and decision
situations. For instance, members suggested that SDM
interventions including decision aids and communication
training will need to allow for adaptation to meet the
needs of individual patients, clinicians, health care orga-
nizations, and for the specific medical decision being
considered.
Phase 2: Stakeholder Survey
Participants and Data Collection. Based on the key find-
ings from Phase 1, we designed a web-based open-ended
survey and invited a purposeful sample of members from
the aforementioned workgroup and additional patient
advocates, clinicians, researchers, health systems leaders,
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and funders (n = 47) to complete the survey. The objec-
tive of the survey was to generate actionable recommen-
dations from these diverse stakeholders of ways to
increase consistent use of SDM in practice. A list of 86
potential participants was generated based on discussion
among the core group with the goal of obtaining the per-
spectives from different stakeholders who are knowledge-
able about SDM and represent different organizations
and perspectives. Potential participants were invited via
email and completed the survey through the REDCap
platform (Online Appendix A). Those who agreed to
participate were asked to identify their primary role (e.g.,
patient advocate [n = 4], clinician [n = 10], researcher
[n = 21], health system leader [n = 4], policymaker [n =
2], or funder [n = 5]). One individual did not select a
role. They were also asked to choose one decision sce-
nario that they felt SDM was most important (e.g., HPV
vaccine, prostate-specific antigen screening, screening
mammography, genetic testing for cancer risk, adjuvant
chemotherapy for early-stage breast cancer, making deci-
sions about stopping or forgoing aggressive curative
treatment, or other). Those who selected other scenarios
wrote to specify that they thought SDM were equally
important in all situations and not just one of the above-
mentioned scenarios or specific alternative treatment sce-
narios (e.g., depression, chronic conditions, deciding on
medications). Participants were then asked to provide
their recommendations for ways to increase the adop-
tion, implementation, and sustained use of SDM in prac-
tice based on their selected role and decision scenario
(Online Appendix B).
Analysis. Responses were coded using the qualitative
analysis software NVivo (version 11). Two coders (DM
and SJL) reviewed the survey responses to identify
potential themes for coding. The unit of analysis was at
the level of individual participants, and the unit of cod-
ing was the response to each question within the survey.
After reading through a subset of responses (n = 3),
coders defined the following primary themes: 1)
Evaluation, 2) Level of intervention, 3) Obtain stake-
holders’ involvement, 4) Raise awareness, and 5)
Support SDM use. Three of the primary themes were
further coded into more specific subthemes (Evaluation,
Level of intervention, and Support SDM use). For
instance, the primary theme ‘‘Support SDM use’’ included
subthemes for training, tools, funding or reimbursement,
culture, and other support. We created a codebook
(Online Appendix C) that defined each of the primary
themes and subthemes to facilitate consistency across
coders for the remaining responses. Coders met regularly
to review and discuss disagreements for any theme or sub-
theme. Disagreements were resolved by consensus follow-
ing discussion between the coders. The coders achieved an
average kappa score above .75 for all codes. We analyzed
the themes and subthemes by stage of implementation
(adoption, implementation, and maintenance), role that
the participant identified with, the selected decision sce-
nario, and also by the level of intervention.
Results. Table 1 summarizes the most frequent themes
based on participants’ recommendations for increasing
adoption, implementation, and maintenance of SDM.
For increasing adoption, the most frequent themes were
providing tools to support SDM (n = 11) followed by
obtaining stakeholders’ involvement (n = 9). For
instance, participants recommended the use of decision
aids, provider recommendations, and ‘‘better tools for
Table 1 Recommendations for Increasing SDM Adoption, Implementation, and Maintenancea
Adoption Implementation Maintenance
Provide tools to support SDM 11 12 6
Obtain stakeholders’ involvement, discussion, and communication
including patients, families, clinicians, and health systems leaders
9 10 9
Raise awareness and/or advocacy to promote SDM 6 6 8
Evaluate outcomes of SDM to make sure it is beneficial 6 4 3
Provide training for clinicians and patients to use SDM 6 4 2
Funding or reimbursement to implement SDM 6 3 5
Determine feasibility of SDM in practice 3 4 0
Evaluate process by following up to make sure SDM is happening 2 4 5
Culture change to make SDM the norm 3 1 1
SDM= shared decision making.
aFrequencies refer to number of respondents who indicated a recommendation related to the theme or subtheme. Individual responses may be
coded as more than one theme.
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clinicians to use to help describe to patients the benefits,
risks, harms, and costs of various treatments.’’
For obtaining stakeholders’ involvement, suggestions
included ‘‘having the providers at the table when the
research project is being designed,’’ including family
members early in the treatment conversation, and bring-
ing the clinical leaders together to discuss the issues per-
taining to SDM adoption in practice.
Participants also recommended providing tools (n =
12) and obtaining stakeholders’ involvement, discussion,
and communication (n = 10) as the most frequent ways
to increase implementation. Recommendations related to
these themes for the implementation of SDM include
integration of SDM tools within the electronic health
record and existing care workflow, convening patient and
family councils to review the quality of clinical care,
involving the patient’s voice, and working with commu-
nity members on the development of SDM in practice.
For instance, one participant recommended ‘‘integrat[ing]
patient voice into practice management to assure that
patient perspective is considered in design, implementa-
tion, assessment and maintenance of practice operations,
including but not limited to shared decision making.’’
To sustain maintenance of SDM use, participants
most frequently recommended obtaining stakeholders’
involvement (n = 9) followed by raising awareness or
advocacy (n = 8). An example of recommendations to
obtain stakeholders’ involvement was to regularly reas-
sess the patient’s values regarding their health and having
multiple conversations so the patient is aware of their
ongoing treatment. Suggestions for raising awareness
included political advocacy for metrics to measure clini-
cian effectiveness in SDM, developing learning networks
to promote SDM models, and presenting the benefits of
SDM at scientific meetings.
Overall, providing tools to support SDM, obtaining
stakeholders’ involvement, and raising awareness were
the most common recommendations across different self-
identified roles of the participants, the decision scenario,
and levels of intervention. Table 2 summarizes illustra-
tive quotes from each theme/subtheme based on partici-
pants’ recommendations.
Phase 3: Multistakeholder Working Session
Participants. Drawing from the findings obtained in
Phase 1 and Phase 2, the core group identified three pro-
mising action priorities for increasing SDM use in rou-
tine care across multiple levels: 1) design a guide for
implementation of SDM in clinical settings, 2) dissemi-
nate educational curricula on SDM, and 3) influence
policies to increase SDM use. We convened a working
session at the 2017 Annual Conference on the Science of
Dissemination and Implementation in Health. The work-
ing session comprised 30 stakeholders including some of
the participants from Phases 1 and 2 and additional sta-
keholders identified by the core group to have relevant
expertise in SDM and/or implementation science based
on their current and prior work. Patient advocates, clini-
cians, researchers, health system leaders, policymakers,
and funders were represented at the working session. The
working session was not limited to conference attendees
and included stakeholders who were invited specifically
for the session. The objective of the working session was
to obtain specific strategies from various stakeholders
who self-selected into one of three breakout group dis-
cussions addressing each of the three action priorities.
For the group addressing characteristics of a guide for
implementation of SDM, participants were asked to rec-
ommend key components of such a guide, adaptations
and customization of SDM for different settings, track-
ing the progress of SDM implementation, and research
that would be needed to develop and evaluate the guide.
The implementation guide is intended to include key
components to be consistently implemented and also to
consider the contextual factors unique to each health care
environment and to facilitate the implementation of
SDM. This balance between fidelity to the core compo-
nents of SDM and appropriate adaptation to local con-
text is another contribution of implementation science to
this work as both fidelity and appropriate adaptation to
local contexts are needed.23,42 Participants in the second
group addressing educational curricula were asked to rec-
ommend strategies to facilitate adoption of SDM training
curricula in medical, nursing and allied health schools, fel-
lowship programs, and among practicing clinicians.
Finally, participants in the third group addressing policies
to increase SDM use were asked to recommend target
audiences for policy intervention, strategies to engage
these audiences for policy change, and essential questions
to answer to influence policy. This group included experts
in health care communication, health care professional
training, SDM training curricula development, or were
patient advocates who have advocated for SDM training.
Participants were asked to complete a brief survey provid-
ing their recommendations for their breakout group
topic.
Results. Table 3 summarizes key recommendations from
each breakout group discussion, and Table 4 presents
illustrative quotes from participants’ responses to the
brief survey.
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Designing a guide for implementation of SDM in clini-
cal settings. Participants identified key components of
an implementation guide including defining SDM and
specific measures for SDM, built-in prompts or
reminders to trigger SDM within the existing workflow,
incorporating patient preferences, clinician feedback,
and a tracking system. Participants recommended allow-
ing for adaptation and customization to different health
Table 2 Illustrative Quotes From Stakeholder Survey
Theme/Subtheme Quote
Evaluation
Outcomes ‘‘Feedback loops regarding effectiveness of the SDM tools. Effectiveness could/should be
measured on patient reported measures (e.g., satisfaction, QOL, etc.).’’
Process ‘‘Culture change, training in principles and techniques, better ways to document and measure
SDM to know it is actually happening in practice (rather than something else, like just
giving a decision aid).’’
Feasibility ‘‘Conduct well-designed stakeholder-engaged studies to show the feasibility and value for all
stakeholders, and work closely with a full range of supportive stakeholders to facilitate
adoption by identifying and working to overcome barriers.’’
Other evidence ‘‘Revisit decisions after they have been made and implications are clear. Revisit decision
trees that led to current choices.’’
Level
Patient and/or family ‘‘Give patients the time to think about the items in the SDM tool, but set a clear deadline for
when you will return to discuss their thoughts and values (otherwise patients may avoid
these questions because they are difficult issues and this will not be done). Offer support to
the patient to use the SDM tool, that is, offer to have the social worker, chaplain, or
palliative care or family members work with the patient to elicit their values and
preferences.’’
Provider and/or practice ‘‘Develop simple methods to apply a shared decision-making tool in clinical practice—
incorporate it into the electronic health record and include a simple training video with the
tool to help providers recognize how to use it—and to provide links to additional free
archives webinars that give more in-depth training on how to use it.’’
System ‘‘SDM has most chance of success if included as part of a larger system of coordinated care
that supports a team-based, multidisciplinary approach with patients and caregivers.’’
Other levels ‘‘Again, working with community members on the development and delivery (how do they
want to hear about it, from who, when, what media) and then taking answers to those
questions into consideration in developing the stakeholder group that will champion
delivery. Acknowledging the answers to these questions will vary by community and
experience with historical distrust of medical and research professionals.’’
Obtain stakeholders’
involvement, discussion,
and communication
‘‘External pressure from patients, families, and communities. Give them a voice and some
real power.’’
Raise awareness and/or
advocacy
‘‘Raise awareness! Give us a campaign (posters and short/simple YouTube) to spread among
patient communities.’’
Support
Tools ‘‘Better tools for clinicians to use to help describe to patients the benefits, risks, harms, and
costs of various treatments.’’
Training ‘‘Training clinicians in what SDM means and how to have the conversations. Connecting
with guidelines (which seem to drive adjuvant therapy decisions) to place more emphasis on
variation in patient preferences, risk tolerance, etc.’’
Culture ‘‘Cultural change is key. In theory, many agree that shared decision making is important, but
on the ground, clinical enterprises are still very much provider-centric. The voice and
choice of the patient is not nearly valued as much as the voice/choice of the ‘expert’
provider. Until that power differential exists, it will be hard to have true ‘shared’ decision
making. This power differential is particularly real for patients that come from diverse
ethnic and cultural background and/or come from lower SES.’’
Funding/reimbursement ‘‘Make it a normal, expected, quality, reimbursed part of care.’’
Other support ‘‘Develop system for providing patients with information (e.g., written); develop mechanisms
for standardized time/workflow; have some follow-up or check-in for completion’’
QOL, quality of life; SDM, shared decision making; SES, socioeconomic status.
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Table 3 Summary of Specific Recommendations From Breakout Group Discussions in Phase 3
Group 1: Designing a guide for implementation of SDM in clinical settings.
Key components of adaptation guides  Have a specific and measurable definition of SDM
 Include the ability to identify eligible population
 Incorporate a tracking and monitoring system
 Elicit patient preferences
 Allow provider feedback
 Ensure the guide is integrated with the clinics’ workflow
 Show evidence-based visual representations of risk and benefits
 Build in prompts/reminders within the system
SDM adaptations and customizations  Consider workflow and how to integrate SDM into workflow
 Allow customization to different practice settings
 Allow adaptation to fit system, setting, workflow, provider input and
tracking and patient preference
 Create a framework with primary stakeholder (end users), with
interchangeable details within model (interchangeable parts theory).
 Track fidelity of adaptation
SDM implementation progress tracking  Track implementation results and adaptations made
 Specify what will be tracked, how, and when to report or provide feedback
to decision makers
 Train staff on what will be tracked and account for patient preferences
 Design ‘‘EHR/certification’’ that SDM has occurred that is not easy to
‘‘game’’
Needed research for guide development
and application
 Determine the minimum eligibility criterion for when to implement SDM
 Isolate the most parsimonious set of strategies to support SDM
 Determine when is the optimal time to ‘‘trigger’’ engagement with patients in
SDM
Group 2: Disseminate educational curricula on SDM
Strategies to ensure wide adoption of
SDM curricula among medical,
nursing, and allied health professional
schools
 Work with school leadership to create culture for SDM
 Provide adequate role models among faculty and clinicians for students
 Timing of SDM training—Expose students early to increase awareness and
later to get hands-on experience
 Incorporate SDM competency as part of National Board of Medical
Examiners (NBME) clinical skills exams
Strategies to ensure wide adoption of
SDM curricula among residency/
fellowship programs
 Provide role models and direct observation of senior clinicians for trainees
 Build SDM into competency for graduating or completing course/rotation
Strategies to ensure wide adoption of
SDM curricula for continuing
education among practicing health
professionals
 Institute health system policies to require annual SDM training of all
clinicians
 Build the organizational and professional culture to support SDM
 Tie SDM training to existing metrics such as patient experience, physician/
employee benefit
 Use the intrinsic lever of providing best care
 Develop good SDM metrics
Group 3: Influencing policies to increase SDM use
Targets for policy interventions  Target national agencies—Centers for Medicare and Medicaid Services
(CMS), National Quality Forum (NQF), National Committee for Quality
Assurance (NCQA)
 Engage with states (e.g., Washington state), health lawyers, and health
systems (e.g., Kaiser Permanente)
 Convene patient advocacy groups (Partnership to Improve Patient Care
[PIPC], Society for Participatory Medicine [S4PM], Faster Cures, etc.)
Strategies to engage these groups  Support the process of regulation of decision aids, for example, NQF
 Work with government relations and reimbursement experts
 Determine the return on investment, business case or value proposition for
all stakeholders using decision tools, for example, health care system,
patients, doctors, and policymakers
 ‘‘Pick your battles’’ and focus on SDM for high-impact situations, for
example, costly and preference-sensitive decisions/domains
Essential questions to answer to
influence policy
 Create certified, high-impact SDM tools and aids before beginning
implementation
 Conduct case studies of states that created a favorable policy landscape for
SDM, for example, Washington
SDM, shared decision making.
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systems, setting, workflow, provider, and patient prefer-
ences, and tracking fidelity of the adaptation. Addressing
this recommendation, one participant suggested using
‘‘the interchangeable parts theory, creating a framework
with primary stakeholders (end users), with interchange-
able details within [the] model.’’
Disseminate educational curricula on SDM. Key rec-
ommendations related to education included early expo-
sure to SDM and repeated training over the arc of health
professionals’ education and career to ensure adoption.
Another recommendation was to ensure adequate role
modeling by practicing clinicians for trainees and junior
clinicians such that SDM skills learned through educa-
tional curricula are consistently practiced and not dis-
couraged. Participants further described incentives and
levers to promote SDM as a required skill, such as pro-
viding continuing education credits to support team-
based implementation of SDM, including SDM within
clinical certification examinations, employment policies
for clinicians requiring annual SDM training, and con-
necting SDM training to existing metrics such as patient
experience and benefits to physicians and employees.
One participant recommended training the public begin-
ning in grade school to be able to enact SDM conversa-
tions at each visit with their health care provider.
Table 4 Illustrative Quotes From Working Session Breakout Group Discussions
Group 1: Designing a guide for implementation of SDM in clinical settings
Key components of adaptation
guides
‘‘Way to identify eligible population. Core and optional components of SDM.
Ways to track and monitor progress. Roles-definition and process tools.
Itemize and document.’’
SDM adaptations and
customizations
‘‘Using the interchangeable parts theory, creating a framework with primary
stakeholder (end users), with interchangeable details within model. Each
discipline may have differing specifics, but the process framework seems
universal.’’
SDM implementation progress
tracking
‘‘Incorporate into workflow. Engage and train staff. Engage stakeholders and
build consensus about timing and tracking procedures. Account for patient
preferences.’’
Needed research for toolkit
development and application
‘‘Need to isolate/test the most parsimonious set of strategies to support SDM
delivery with fidelity.’’
Group 2: Disseminate educational curricula on SDM
Strategies to ensure wide adoption
of SDM curricula among
medical, nursing, and allied
health professional schools
‘‘Work with student organizations like American Medical Student Association
to create the ground swell for culture of SDM.’’
Strategies to ensure wide adoption
of SDM curricula among
residency/fellowship programs
‘‘Need for role models and direct observation. Build into competency for
graduating or completing course/rotation.’’
Strategies to ensure wide adoption
of SDM curricula for continuing
education among practicing
health professionals
‘‘Provide CE across multiple disciplines to support team based implementation.’’
Other strategies ‘‘By the way we need to train the public in this starting in grade school! Every
patient should have a clear sense of the question ‘What’s important to you?’
before each visit. This must be taught.’’
Group 3: Influencing policies to increase SDM use
Targets for policy interventions ‘‘Focus on CMS. Their decision to pay for SDM is huge. We should push them
to incentivize SDM for more treatment decisions, and help them by advocating
for a certifying body to ensure SDM is done well.’’
Strategies to engage these groups ‘‘Know your context (ecosystem)-where is the perceived need greatest? Know
your competition-competing messaging and behaviors. Focus the message on
providing a solution for ‘jobs to be done’ of your target audience adopter, for
example, meeting accreditation, saving money, meeting patient demand or
satisfaction’’
Essential questions to answer to
influence policy
‘‘Do a case study of Washington State to examine how policy levers, health
systems, patient voice, regulation/certification, and payment approaches
combined to create a favorable landscape for SDM.’’
CE, continuing education; CMS, Centers for Medicare and Medicaid Services; SDM, shared decision making.
10 MDM Policy & Practice 00(0)
Influencing policies to increase SDM use. Participants
identified several key target audiences for influencing
policy interventions to promote SDM. These included
national organizations (e.g., Centers for Medicare
and Medicaid Services, National Quality Forum, and
National Committee for Quality Assurance), patient
advocacy groups (e.g., Partnership to Improve Patient
Care, Society for Participatory Medicine, and Faster
Cures), states, health lawyers, and health systems. The
group recommended specific strategies to best engage
with these groups that included identifying the value pro-
position for various stakeholders involved in implement-
ing SDM and focusing on SDM for high-priority
decision situations (e.g., costly and preference-sensitive
treatment decisions). For example, one participant rec-
ommended ‘‘choos[ing] the decision context carefully
based upon disease burden and variability that leads to
overtreatment and undertreatment.’’
Discussion
Our findings are consistent with current literature
describing multilevel factors as key influences on SDM
implementation including organizational and health care
system characteristics.17,43,44 For instance, we obtained
recommendations from diverse stakeholders obtained in
Phases 2 and 3 of our work to conduct SDM and com-
munication skills training for health care professionals,
provide tools to support SDM, and raise awareness of
the importance of SDM. Similarly, Scholl et al. summar-
ized strategies to address organizational- and system-
level characteristics, which included supporting health
care professionals in learning SDM skills, making deci-
sion aids and tools more accessible in exam rooms and
workplaces, and promoting a strong consistent message
about the importance of SDM.17
In addition, this research adds to the literature in the
following ways. First, we obtained more detailed input
on specific ways to achieve these recommendations for
improving SDM use compared with those described in
the Scholl et al. review, which the authors deemed as
vague and needing further specification and tailoring to
a specific context.17 Second, the recommendations we
obtained from diverse stakeholders were also more com-
prehensive and spanned multiple levels influencing SDM
implementation compared with prior reviews that
focused on either individual factors or organizational/
system-level factors but not across these levels of influ-
ences.17,18,43,45 In sum, this study informs future research
and applications to focus on promising strategies at mul-
tiple levels including to enhance SDM use. The current
work provides an example for integrating principles of
implementation science with SDM research to inform
promising and novel strategies for SDM adoption,
implementation, and sustainment in routine practice
using an implementation science model and approaches
(PRISM).
There is growing interest from clinicians, health sys-
tems, and funding agencies in utilizing an implementa-
tion science framework for advancing evidence-based
SDM interventions in health care settings.14,46 There are
several implementation science frameworks that could be
used to approach this issue, including the Consolidated
Framework for Implementation Research that has
described characteristics of inner and outer settings to
influence implementation.47 We elected to use the
PRISM (and its component RE-AIM dimensions) to
inform our work because of the objective of obtaining
recommendations that were specific to the phases of
adoption, implementation, and maintenance. Funding
agencies including the Patient-Centered Outcomes
Research Institute have also initiated opportunities to
target implementation science approaches in SDM
delivery.48
One of the key findings that emerged from the work
reported here is that translating SDM into practice is
complex and requires an in-depth understanding of and
attention to multilevel contextual factors. Contextual fac-
tors include not only characteristics of the patient, clini-
cian, or the health care organization but also the specific
health care decision under consideration. Each of these
factors has the potential to influence whether and how
SDM occurs. Both the design of interventions to support
SDM and the strategies used to implement those inter-
ventions in practice will need to differ to fit diverse set-
tings. For example, implementing a decision support tool
in an outpatient setting around prostate cancer screening
will require a decision support strategy that considers the
time pressures and competing demands of the outpatient
clinicians, the availability of other staff to do SDM, and
the desire of the patient for SDM. In contrast, a patient
faced with a decision of whether to pursue additional
chemotherapy or transition to hospice care will have very
different needs, and the optimal decision support strategy
may be having the oncologist respond effectively to emo-
tions and present prognosis information empathetically.
Another key lesson from this work is that a coordi-
nated approach to engage all stakeholders is critical to
ensuring success in efforts to plan, deliver, implement,
and sustain SDM in routine practice. This message
emerged consistently as one of the top recommendations
from our stakeholder survey in Phase 2. Effective
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stakeholder engagement will require understanding
their priorities, obtaining their buy-in and commitment,
building strong working relationships at each phase of
the SDM intervention, identifying contribution and
resources from each stakeholder, sharing data on
whether SDM is occurring as planned, and demonstrat-
ing the value and impact of SDM for each stakeholder
from their perspectives. For instance, access to tools and
training for health care professionals throughout their
careers and to patients was a key priority that would
help them engage in SDM effectively with one another.
Clinicians recommended that tools to support SDM
should be integrated within their workflow to ensure that
they would be utilized. In addition, patient advocates
wanted greater representation of the patients’ voice in
developing SDM interventions. From health care system
leaders’ and funders’ perspective, it would be important
to measure and highlight the business case and value
proposition for SDM use. Ultimately, ongoing and sus-
tained engagement with all relevant stakeholders is
needed to motivate sustainable organizational and cul-
tural change to value SDM as an integral part of high-
quality health care.
The broader policy and resource challenges to support
SDM use in practice should be acknowledged in priori-
tizing the recommendations obtained in this work. For
example, the Center for Medicare and Medicaid
Innovation (CMMI) announced in 2016 an incentive
model to provide financial support for accountable care
organizations (ACOs) to invest in a structured process of
integrating SDM into clinical practice and to reimburse
ACOs for SDM services (e.g., for lung cancer screening).
However, the model was discontinued in 2017 following
low participation among the ACOs. The Agency for
Healthcare Research and Quality (AHRQ) has the
SHARE Approach and published the training curricu-
lum and implementation tools although it is unclear if
the SHARE Approach is being supported. In 2016,
AHRQ had issued a funding announcement focused on
development of SDM measures. To our knowledge, no
study has been funded under this announcement.
Although research support to develop evidence-based
SDM tools is available, the field faces challenges in sup-
porting the dissemination and updating of these tools
once they are developed. For example, evidence-based,
certified, and well-designed decision aids may not be
available for certain conditions, and more important,
even when they are available, they may be hard to inte-
grate into the clinical workflow. Given the earlier interest
from CMS/CMMI to reimburse providers for delivery of
SDM services, efforts should be targeted at CMS to
incentivize SDM for more medical decisions and to
support CMS through certification of evidence-based
SDM tools, monitoring and reporting of performance of
SDM, and measuring health outcomes arising from
SDM.
The work reported here has both strengths and limita-
tions. Strengths include the use of a sequence of meetings
and different data collection methods and the diverse
perspectives involved. The descriptive quantitative survey
data are clarified through qualitative coding and illustra-
tive quotes. One limitation is despite considerable recruit-
ment efforts, there were few participants for some roles
(e.g., policymakers, patient advocates) to investigate pos-
sible differences among stakeholders from these different
roles. Second, real-world patients’ and clinicians’ voices
may be underrepresented within the purposive samples
of academic clinicians and professional patient advo-
cates. Future research should involve diverse stake-
holders including patients and clinicians to provide their
perspectives on practicing SDM in real-world settings.
In conclusion, although preliminary, this report iden-
tified several key recommendations from an implementa-
tion science perspective that appear fruitful for further
study and application. We summarized specific recom-
mendations from stakeholders to develop adaptation
guides for implementing SDM in practice, enhance the
adoption of educational curricula in SDM, and influence
policy actions to support SDM. This effort both revealed
the complexity involved in getting SDM approaches con-
sistently into practice and also identified several promis-
ing ways to address these challenges.
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